Monthly Archives: November 2022


No Survival Benefit for Invasive Management of Stable CAD

An interim report of a US randomized trial in patients with stable coronary disease and moderate or severe ischemia concluded that there was no difference in all-cause mortality for an initial invasive strategy compared with an initial conservative strategy, with lower risk of cardiovascular mortality but higher risk of non-cardiovascular […]


Intensive BP Control Harmful After Endovascular Thrombectomy for Acute Ischemic Stroke

An open-label, blinded-endpoint, randomized controlled trial in China suggested that intensive control of systolic blood pressure (SBP) to lower than 120 mm Hg should be avoided to prevent compromising the functional recovery of patients who have received endovascular thrombectomy due to intracranial large-vessel occlusion. The trial enrolled 821 patients (aged […]


Gum Disease Linked to Atrial Fibrosis

A prospective histological cohort study in Japan revealed the association of periodontitis with atrial fibrosis. The study enrolled 76 patients with atrial fibrillation (AF, 55 with nonparoxysmal AF, 25 with mitral valve regurgitation, 18 with left atrial appendages [LAA] thrombus) who were scheduled to undergo LAA excision during cardiac surgery. […]